CH
China Traditional Chinese Medicine Holdings Co. Limited
CHIZF · OTC
$0.16 +0.00% (+$0.00)
Market Cap ¥5.50B
P/E Ratio -
Div. Yield -
ROE 1.62%
Bulios Fair Price
$0.22
34.9% upside
Current Price
$0.16
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CHIZF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.38x
P/B 0.27x
P/FCF 2.81x
Growth
50 /100
Stable FCF growth 51.29%
Book val. growth 0.52%
Rev. growth 0.14%
Profitability
47 /100
Moderate Net margin 2.32%
Op. margin 2.07%
FCF margin 13.62%
Quality
6 /100
Poor ROE 1.62%
ROA 1.03%
Asset turnover 0.44x
Debt
88 /100
Low Current ratio 2.29x
Int. coverage 3.08x
Net debt/EBITDA -1.11x
Stability
41 /100
Moderate Rev. volatility 21.82%
EPS volatility 418.16%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CHIZF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jun Yang
Employees
14,846
Headquarters
Hong Kong
Upcoming events
19 MAR
Earnings
Upcoming earnings report